Circulation Research, Vol 53, 131-139, Copyright © 1983 by American Heart Association
ARTICLES |
J Taniguchi, A Noma and H Irisawa
Effects of varying the intracellular adenosine triphosphate level on both the action potential and the membrane current were studied in single ventricular cells isolated from the guinea pig heart, using collagenase. Intracellular injection of adenosine triphosphate elevated the plateau potential level and prolonged the action potential duration. Similar results were obtained by injecting adenosine diphosphate, adenosine monophosphate, or creatine phosphate, i.e., substances considered to increase the intracellular concentration of adenosine triphosphate. In contrast, the action potential was depressed by procedures which could reduce the intracellular adenosine triphosphate level, such as an injection of creatine, superfusion of glucose-free Tyrode's solution containing 5.4 mM cyanide ion, or an injection of adenosine monophosphate into the cyanide-superfused cell. When the membrane current was recorded under the voltage clamp, it was found that the injection of adenosine triphosphate increased the amplitude of the slow inward current, whereas the superfusion of cyanide ion did not significantly decrease the slow inward current, although the action potential became considerably shorter. It was also found that the adenosine monophosphate injection decreased the amplitude of the net outward membrane current at the plateau level and increased it at around -40 mV, and thus intensified the N-shape of the isochronal 0.3-second current-voltage curve. The cyanide ion superfusion produced the opposite effect; in response to depolarizing clamp pulses more positive to the plateau level, the membrane current increased significantly with cyanide ion, but increased only slightly with adenosine triphosphate. These results suggest that intracellular adenosine triphosphate modifies the membrane currents at the plateau potential range, thus altering the action potential duration.
This article has been cited by other articles:
![]() |
E. Carmeliet Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias Physiol Rev, July 1, 1999; 79(3): 917 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Schotborgh and A. A.M. Wilde ATP-Sensitive Potassium Channel Openers and Blockers in the Cardiovascular System: Physiology, Pharmacology, and Clinical Effects Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 243 - 255. [Abstract] [PDF] |
||||
![]() |
V. A Losito, R. G Tsushima, R. J Diaz, G. J Wilson, and P. H Backx Preferential regulation of rabbit cardiac L-type Ca2+ current by glycolytic derived ATP via a direct allosteric pathway J. Physiol., August 15, 1998; 511(1): 67 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
B O'Rourke, P. Backx, and E Marban Phosphorylation-independent modulation of L-type calcium channels by magnesium-nucleotide complexes Science, July 10, 1992; 257(5067): 245 - 248. [Abstract] [PDF] |
||||
![]() |
S. Hamilton, A Yatani, M. Hawkes, K Redding, and A. Brown Atrotoxin: a specific agonist for calcium currents in heart Science, July 12, 1985; 229(4709): 182 - 184. [Abstract] [PDF] |
||||
![]() |
J. C. Koster, A. Knopp, T. P. Flagg, K. P. Markova, Q. Sha, D. Enkvetchakul, T. Betsuyaku, K. A. Yamada, and C. G. Nichols Tolerance for ATP-Insensitive KATP Channels in Transgenic Mice Circ. Res., November 23, 2001; 89(11): 1022 - 1029. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |